and metformin in patients with type 2 dia-betes mellitus insufﬁciently controlled withdiet and sulfonylureas: a randomized, pla-cebo-controlled study. Diabet Med 16:755– 761, 1999 31. Blonde L, Rosenstock J, Mooradian AD, Pipe BA, Henry D: Glyburide/metformincombination product is safe and efﬁca-cious in patients with type 2 diabetes fail-ing sulphonylurea therapy. Diabetes Obes Metab 4:368–375, 2002 32. DeFronzo RA, Goodman AM: Efﬁcacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333:541–549, 1995 33. Gregorio F, Ambrosi F, Marchetti P Cris- tallini S, Navalesi R, Brunetti P, FilipponiP: Low dose metformin in the treatment oftype II non-insulin-dependent diabetes:clinical and metabolic evaluations. Acta Diabetol Lat 27:139–155, 1990 34. Higginbotham L, Matin FI: Double-blind trial of metformin in the therapy of non-ketotic diabetics. Med J Aust 2:154–156, 1979 35. Cusi K, Consoli A, DeFronzo RA: Meta-